ArticleInternational psychogeriatrics2018

Use of FDA approved medications for Alzheimer's disease in mild dementia is associated with reduced informal costs of care.

Stephanie Behrens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.